Portabel Health: Crowned Winner of Flemingsberg Science STARTUP Award 2025

Quickly finding the right personnel is one of the healthcare sector’s major challenges, especially in times of staff shortages and increasing demands for efficiency. Portabel Health offers a modern solution to these problems through a digital platform that makes it easy for care providers to access qualified nurses and healthcare professionals.

Unlike traditional staffing agencies, Portabel Health enables flexible and cost-effective staffing, where the right competence can be matched with the right assignment on short notice. The platform manages the entire process—from matching and scheduling to communication, resulting in reduced administrative burden.

“Winning the Flemingsberg Science Award STARTUP 2025 is proof that we’re on the right path and that our work is being recognized. It gives us even more motivation to continue building a solution the healthcare system truly needs.” — Omar Ahmed, COO and Co-Founder

By combining technology with a deep understanding of healthcare needs, Portabel Health helps ensure high quality of care—even during sudden changes in staffing. The result is a more sustainable staffing solution that strengthens both the work environment and patient care.

“This win opens doors for us to grow faster and continue developing in an environment that fosters innovation. It’s a significant step in our journey and in our mission to create societal value.” — Abdullah Hariss Qurashi, CEO and Founder of Portabel Health

Portabel Health’s innovative work has not gone unnoticed. This year, they are the winners of the Flemingsberg Science STARTUP Award. In addition to the prize of 10,000 SEK, they gain access to coworking spaces in Novum Labs—a creative, knowledge-driven hub for the next generation of tech and healthcare companies, located in the heart of Flemingsberg.

Cluster Engine Flemingsberg – ERDF Project for Growth in Life Science

Flemingsberg is taking a significant step towards establishing itself as a central player in Life Science with the launch of the “Cluster Engine Life Science Flemingsberg” project. The project has been granted funding from the European Regional Development Fund and aims to strengthen the growth and establishment of small and medium-sized enterprises (SMEs) within the life science sector in the Stockholm region. The total project budget is €10.8 million for the years 2025–2027.

BioLamina Establishes Operations in Flemingsberg – A Key Player in ATMP Development

As the world’s first and only producer of laminins, the biotechnology company BioLamina has expanded its operations and chosen to establish part of its business in Flemingsberg. Using laminins, a protein that creates an optimal environment for cells to expand and/or differentiate, they are a key player in the development of ATMPs (Advanced Therapy Medicinal Products) in Sweden and globally.

BIO-Europe – A Conference for Future Medical Innovations

BIO-Europe is Europe’s largest partnering conference for the biotechnology, pharmaceutical, and life science industries. The conference serves as a meeting place where companies, researchers, investors, and other stakeholders in the industry can network, establish collaborations, and discuss business opportunities. The event is held annually in various European cities. This year, BIO-Europe took place in Stockholm from November 4th to 6th, where discussions included advanced cell and gene therapies as the medicine of the future.

Previous 131415 Next